ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Surprise Finding On HRT Stops Large Trial, Women Advised To Reconsider Long-Term Use Due to Increased Breast Cancer Risk

July 12, 2002

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974

Funding opportunities listed.

May 7, 2004